Sutro Biopharma (STRO) — Free Cash Flow Generation Index
Sutro Biopharma (STRO) has a Free Cash Flow Generation Index of 0.92x as of June 2024. Free cash flow of $8.70 Million represents 1% of operating cash flow ($9.46 Million). See Sutro Biopharma working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sutro Biopharma Free Cash Flow Generation Index (2018–2022)
Historical FCF Generation Index trend for Sutro Biopharma across 2 annual periods. Explore STRO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sutro Biopharma (2018–2022)
Year-by-year Free Cash Flow Generation Index for Sutro Biopharma. For the full company profile including market capitalisation, see STRO stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.21x | $-4.31 Million | $3.55 Million | $7.86 Million | ▼ -238.4% |
| 2018 | 0.88x | $11.13 Million | $12.68 Million | $1.56 Million | — |